Natalizumab in cerebrospinal fluid and breastmilk of patients with multiple sclerosis

BACKGROUND: Natalizumab is a highly effective monoclonal antibody for the treatment of multiple sclerosis (MS), which can diffuse in different anatomical compartments, including cerebrospinal fluid (CSF) and milk. OBJECTIVES: Starting from incidental detection of natalizumab in the CSF of MS patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Callegari, Ilaria, Schneider, Mika, Aebischer, Vera, Voortman, Margarete M., Proschmann, Undine, Ziemssen, Tjalf, Lindberg, Raija, Fischer-Barnicol, Bettina, Khalil, Michael, Kappos, Ludwig, Kuhle, Jens, Sanderson, Nicholas S.R., Derfuss, Tobias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896084/
https://www.ncbi.nlm.nih.gov/pubmed/36741352
http://dx.doi.org/10.1177/17562864221150040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896084/
https://www.ncbi.nlm.nih.gov/pubmed/36741352
http://dx.doi.org/10.1177/17562864221150040

Ejemplares similares